toyoung said...
All these recent articles and theories on AS and over treatment are very confusing and frustrating for us younger guys (in our 50’s) with low grade PCa ( 1 core out of 12, Gleason 6, PSA<10). Some reports state age doesn’t matter others contradict this statement. Oh What To Do!
Age (life expectancy, actually) is not a contra-indication for Active Surveillance. It simply means that your likelihood of deferred treatment is higher than someone with shorter life expectancy. Those treated with deferred treatment in a well-run AS program have the same outcomes as those treated immediately.
For your assistance, to[o]young, the American Urological Association (AUA) publishes a free online document titled "Guideline for the Management of Clinically Localized Prostate Cancer" (LINK). (Close to 90% of all new diagnosis are "Clinically Localized.")
In my own case, I closely followed the recommendation of this Guideline that each patient closely examine four facts/dimensions about themselves in order to make the most personally appropriate treatment decision: my cancer's characteristics, my overall health, my life expectancy, and my personality/values.
It should not be so bewildering that a very-informed treatment decision might have been different than someone else's, because my (or anyone's) four dimensions (above) are different from everyone else.
I would encourage that newcomers—and especially low-risk newcomers—make a very-informed decision about treatment (including deferred treatment/Active Surveillance, which has been shown to have the highest QoL). The Guideline mentioned above is an excellent tool created specifically to assist newcomers in the decision.